Full Text View
Tabular View
No Study Results Posted
Related Studies
Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis
This study has been completed.
Study NCT01155765   Information provided by University of Patras

First Received on July 1, 2010.   Last Updated on November 15, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemodialysis
Chronic Renal Failure
Additional conditions recognized in this trial
Kidney Failure, Chronic
Renal Insufficiency
More general conditions related to this trial
Kidney Diseases
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
Prasugrel
Clopidogrel
Additional drug interventions recognized in this trial
Ticlopidine
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Purinergic Agents
Purinergic Antagonists
Purinergic P2 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Therapeutic Uses
Sponsors listed in this trial
University of Patras


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services